Last week, we shared news from the European Society of Cardiology Congress 2020: The Digital Experience that was streamed from Amsterdam. We mentioned that we would be back soon with more featured atrial fibrillation science from ESC. We have added the following:
- Results of the STOP-AF FIRST and Cryo-FIRST Trials showing that cryoballoon catheter ablation was safe and effective as a first-line treatment for those with symptomatic paroxysmal atrial fibrillation.
- More details about the new ESC Afib Guidelines and Quality Indicators.
Access those stories at: